BeyondSpring Stock Forecast, Price & News

BeyondSpring (NASDAQ:BYSI) Frequently Asked Questions

Is BeyondSpring a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BeyondSpring in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BeyondSpring stock.
View analyst ratings for BeyondSpring or view top-rated stocks.

How has BeyondSpring's stock price been impacted by Coronavirus?

BeyondSpring's stock was trading at $11.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BYSI stock has increased by 26.4% and is now trading at $14.35.
View which stocks have been most impacted by COVID-19.

Are investors shorting BeyondSpring?

BeyondSpring saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 4,630,000 shares, an increase of 20.3% from the September 30th total of 3,850,000 shares. Based on an average daily trading volume, of 3,470,000 shares, the days-to-cover ratio is presently 1.3 days. Currently, 22.5% of the shares of the stock are short sold.
View BeyondSpring's Short Interest.

When is BeyondSpring's next earnings date?

BeyondSpring is scheduled to release its next quarterly earnings announcement on Tuesday, November 30th 2021.
View our earnings forecast for BeyondSpring.

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) posted its earnings results on Thursday, September, 9th. The company reported ($0.49) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.49). The company had revenue of $0.34 million for the quarter, compared to analysts' expectations of $13.84 million. During the same quarter in the prior year, the business posted ($0.46) earnings per share.
View BeyondSpring's earnings history.

What price target have analysts set for BYSI?

5 brokers have issued 1 year price objectives for BeyondSpring's stock. Their forecasts range from $25.00 to $95.00. On average, they anticipate BeyondSpring's stock price to reach $58.75 in the next year. This suggests a possible upside of 309.4% from the stock's current price.
View analysts' price targets for BeyondSpring or view top-rated stocks among Wall Street analysts.

Who are BeyondSpring's key executives?

BeyondSpring's management team includes the following people:

• Lan Huang, Chairman & Chief Executive Officer
• Richard J. Daly, Chief Operating Officer
• Elizabeth Adkins Czerepak, Chief Financial Officer
• G. Kenneth Lloyd, Chief Scientific Officer
• Ramon W. Mohanlal, Director, Chief Medical Officer, Executive VP-R&D

Who are some of BeyondSpring's key competitors?

Some companies that are related to BeyondSpring include Cassava Sciences (SAVA), Lyell Immunopharma (LYEL), Harmony Biosciences (HRMY), Indivior (INVVY), Nuvation Bio (NUVB), Xencor (XNCR), Nektar Therapeutics (NKTR), Taro Pharmaceutical Industries (TARO), Agios Pharmaceuticals (AGIO), Dynavax Technologies (DVAX), Turning Point Therapeutics (TPTX), Trillium Therapeutics (TRIL), Avid Bioservices (CDMO), Global Blood Therapeutics (GBT) and Erasca (ERAS).
View all of BYSI's competitors.

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), CorMedix (CRMD) and Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

(BYSI) raised $4 million in an initial public offering on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO.

What is BeyondSpring's stock symbol?

BeyondSpring trades on the NASDAQ under the ticker symbol "BYSI."

Who are BeyondSpring's major shareholders?

BeyondSpring's stock is owned by a variety of retail and institutional investors. Top institutional investors include Alliancebernstein L.P. (7.56%), BlackRock Inc. (4.10%), Morgan Stanley (1.16%), Two Sigma Investments LP (0.84%), Tanaka Capital Management Inc. (0.82%) and Citadel Advisors LLC (0.00%).

Which institutional investors are selling BeyondSpring stock?

BYSI stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Apis Capital Advisors LLC, California State Teachers Retirement System, Russell Investments Group Ltd., CNA Financial Corp, and The Manufacturers Life Insurance Company .

Which institutional investors are buying BeyondSpring stock?

BYSI stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Two Sigma Investments LP, Millennium Management LLC, Sectoral Asset Management Inc, Citadel Advisors LLC, BlackRock Inc., Voloridge Investment Management LLC, and Barclays PLC.

How do I buy shares of BeyondSpring?

Shares of BYSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BeyondSpring's stock price today?

One share of BYSI stock can currently be purchased for approximately $14.35.

How much money does BeyondSpring make?

BeyondSpring has a market capitalization of $561.17 million and generates $180 thousand in revenue each year. The company earns $-60.97 million in net income (profit) each year or ($1.93) on an earnings per share basis.

How many employees does BeyondSpring have?

BeyondSpring employs 91 workers across the globe.

What is BeyondSpring's official website?

The official website for BeyondSpring is www.beyondspringpharma.com.

Where are BeyondSpring's headquarters?

BeyondSpring is headquartered at 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005.

How can I contact BeyondSpring?

BeyondSpring's mailing address is 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005. The company can be reached via phone at (646) 305-6387, via email at [email protected], or via fax at 1-646-882-4228.